Drug Pricing Legislation and Inefficient Markets Theory

The inefficient markets theory is being reconsidered after the 2007 financial crisis in the U.S. Is it enough to provide the public with data on the cost of a service or alternative ways to purchase it? In healthcare the intersection of price, quality and sources of suppliers alone does not determine whether pricing is appropriate.

Continue ReadingDrug Pricing Legislation and Inefficient Markets Theory